Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.4
-147.61%
60%
—
-72.32%
40%
—
5 Years
Score3.4
Net Growth-147.61%
Net Trend60%
Net Income Consistency—
Rev Growth-72.32%
Rev Trend40%
Revenue Consistency—
Vir Biotechnology Inc fundamental performance
Across Vir Biotechnology Inc's full reported history, from 2019 to 2025, revenue grew from $ 711K to $ 68M and net income went from -$ 174M to -$ 437M. Revenue increased in 57% of the years measured; net income in 57%.
Vir Biotechnology Inc currently holds a 5-year HDB Score of 3.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 8.96 | — |
1 Year2025-08-12 | $ 4.36 | 105.74% |
5 Years2021-08-12 | $ 41.88 | -78.61% |
All Time2019-10-11 | $ 14.02 | -36.09% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-10-11 |
|---|---|---|---|---|
| Price | $ 8.96 | $ 4.36 | $ 41.88 | $ 14.02 |
| Return | — | 105.74% | -78.61% | -36.09% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 303M | -$ 251M | $ 528M |
| 2025 | $ 68M | -$ 437M | $ 462M |
| 2024 | $ 74M | -$ 521M | $ 905M |
| 2023 | $ 86M | -$ 615M | $ 1.52B |
| 2022 | $ 1.61B | $ 515M | $ 2.40B |
| 2021 | $ 1.09B | $ 528M | $ 708M |
| 2020 | $ 76M | -$ 298M | $ 736M |
| IPO2019 | $ 711K | -$ 174M | $ 383M |
Explore beyond VIR
You're looking at Vir Biotechnology Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
